Clinical Trial Application (CTA) submission marks the advancement of Tangram’s GalOmic RNAi platform into clinical development LONDON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tangram Therapeutics (‘Tangram’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback